Phase I Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg and Novartis Exforge 10/160mg

NCT01494727 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: CJ Amlodipine/Valsartan 10/160mg
DRUG: Novartis Exforge 10/160mg

Sponsor

HK inno.N Corporation